1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
Human Papillomavirus (HPV) Testing Market - Global Outlook and Forecast 2020-2025

Human Papillomavirus (HPV) Testing Market - Global Outlook and Forecast 2020-2025

  • February 2020
  • 236 pages
  • ID: 5862330
  • Format: PDF
  • By Arizton

Summary

Table of Contents

Search Inside

The global HPV testing market is expected to grow at a CAGR of over 12% during the period 2019–2025.

The following factors are likely to contribute to the growth of the HPV testing market during the forecast period:
•Increasing Prevalence of HPV Infections
•Emergence of Point-of-care Diagnostics/Rapid HPV Tests
•Rise of mRNA Test for Cervical Cancer Screening
•Increasing Demand for HPV Co-testing

The increased procurement of the latest-generation HPV testing analyzers and test kits, coupled with the high prevalence of HPV-related infections and cancers, especially cervical and vaginal, influences the growth of the global HPV testing market. Traditionally, cervical cancer screening was based on cervical cytology. However, in recent years, several countries and global health bodies have recommended the inclusion of HPV tests for cervical and pre-cancer screening programs, which is likely to boost the market.

The demand for new innovative testing consumables and instruments using advanced techniques such as the HPV mRNA test, which promotes accurate and sensitive diagnostic outcomes, is driving the market growth. Further, with the availability of positive clinical evidence, demonstrating the superiority of the latest generation advanced testing devices, end-users will become increasingly aware of clinical benefits and rapidly adopt these tests as an essential screening tool for cervical cancer screening. Therefore, the improvement in patient management, favorable government initiatives for primary screening, and the rising awareness of advanced testing in developed and developing economies are increasing the adoption globally.

The study considers the present scenario of the HPV testing market and its market dynamics for the period 2019?2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.

HPV Testing Market: Segmentation

This research report includes detailed segmentation by products, applications, end-user, and geography. The consumables segment is growing due to the high adoption of advanced testing kits, reagents, and other related consumables to detect and screen cervical cancers globally. The segment is also growing at a fast rate due to the recurring purchase by end-users to perform HPV tests. These screening tests are likely to gain wide acceptance in emerging economies due to favorable government initiatives and the rise in consumer spending power. Therefore, market players are focusing on significant product launches in a low resource setting of emerging countries, thereby accelerating the segment growth. The instruments segment is growing at a slow pace as the procurement of analyzers is capital intensive and the purchasing decision depends on financial resources and budget allocations. However, the increasing availability of automated and compact analyzers/instruments has significantly improved the efficiency and quality of end-user operations. Automation and integration of several diagnostic platforms have led to the introduction of innovative diagnostic analyzers, thereby driving the growth during the forecast period.

The cervical application segment is growing on account of the rise in cervical cancer incidences. The increased focus of market players to launch screening products in low resource countries is expected to drive the cervical application segment during the upcoming years. HPV self-sampling is emerging with the rapid availability of these devices as a potential screening strategy, especially in the US, which is likely to contribute to the growth.

The application of HPV testing for vaginal cancer offers powerful negative predictive values. Therefore, the detection of infection with a high-risk HPV, which produce visible signs, is a powerful tool for vaginal cancer screening. Owing to the benefit of HPV testing, coupled with the rise in the vaginal cancer burden globally, vendors are offering innovative testing devices, which are driving the growth of the vaginal application segment.

The increased focus on enhancing the sensitivity of cervical screening to reduce false-negative diagnoses as well as improve the specificity of molecular tests to detect high-risk human papillomavirus is a major factor contributing to the growth of standard reference laboratories. The availability of standard reference laboratory services for the evaluation of HPV DNA and antibody detection in biological specimens through capacity-building worldwide is another reason for the growth of standard reference laboratories.

Healthcare professionals in hospitals use human papillomavirus testing as a screening procedure for the cervical and other related cancers. The market is likely to grow at a fast pace during the forecast period on account of the adoption of advanced testing products. A majority of patients with high-risk symptoms prefer visiting hospitals for diagnosis due to advanced infrastructure facilities available in major private and public hospitals.

The physicians’ office and clinic segment is expected to grow mainly on account of the growing prevalence of cervical cancers worldwide. These clinics perform laboratory screening through private offices for people with a high risk of cervical and other HPV associated cancers at an affordable cost. Another factor responsible for the rise of this segment is the availability of super-specialty expertise in these clinics.

Market Segmentation by Products
•Consumables
•Instruments
Market Segmentation by Applications
•Cervical Cancers
•Vaginal Cancers
•Others
Market Segmentation by End-user
•Standard Reference Laboratories
•Hospitals
•Physicians’ Office and Clinics

Insights by Geography

North America is growing at a significant rate due to the growing preference for HPV tests to detect and screen cervical cancers and other related infections. The presence of a large pool of population with a high risk of developing cervical cancer, the increasing acceptance of HPV testing, and growing awareness of advanced testing procedures have accelerated the market.

Germany, France, the UK, Spain, and Italy are the leading contributors to the Europe market. The presence of highly sophisticated healthcare infrastructure, a high awareness level of advanced HPV screening procedures with high analytic sensitivity for detecting cervical cancers, and increased investment in R&D activities are the major drivers for the growth in the region.

The region has the largest population density and the highest population with a high risk of developing cervical cancers and other associated infections. Japan, China, Australia, South Korea, and India are the major revenue contributors from the region. Japan is the major revenue contributor to the HPV testing market in APAC due to advancements in healthcare infrastructure, the rise in healthcare expenditure, and favorable public and private initiatives for an increase in the healthcare access.

Market Segmentation by Geography
•North America
oUS
oCanada
•Europe
oGermany
oFrance
oUK
oSpain
oItaly
•APAC
oJapan
oChina
oIndia
oSouth Korea
oAustralia
•Latin America
oBrazil
oMexico
oArgentina
•MEA
oTurkey
oSouth Africa
oSaudi Arabia

Insights by Vendors

The global HPV testing market is highly competitive and characterized by the presence of several global, regional, and local players. F. Hoffmann-La Roche, QIAGEN, Hologic, and Abbott are the dominant players, and their testing instruments and consumables are widely used by end-users globally. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on innovation and research activities. Over the years, these players have been dominating the market as they have introduced safe and efficient products in the market. Vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and strategic partnerships to expand their presence, enhance product portfolio, and improve expertise in the market.

Key Vendors
•Hoffmann-La Roche
•QIAGEN
•Hologic
•Abbott

Other Vendors
•Arbor Vita
•BD
•Cepheid
•DAAN Gene
•DiaCarta
•Fujirebio
•Greiner Bio One International
•Hybribio
•IncellDx
•Norgen Biotek
•PreTect
•Seegene
•Siemens Healthineers
•Takara Bio
•Xiamen Zeesan Biotech
•ZYTOVISION

Key Market Insights
The analysis of the global HPV testing market provides sizing and growth opportunities for the forecast period 2020–2025.
•Offers sizing and growth prospects of the market for the forecast period 2020–2025.
•Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market.
•Includes a detailed analysis of growth drivers, challenges, and investment opportunities.
•Delivers a complete overview of segments and the regional outlook of the market.
•Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($3500)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2020

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on